Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) today announced that it has priced an underwritten public offering of 7,089,553 shares of common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE